ArticleDevelopmental biology2026
Ascl1 promotes OPC specification across species and central nervous system regions and its gliogenic function is regulated by phosphorylation.
Article in Developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
In the developing central nervous system (CNS), neural progenitors first generate neurons before making astrocytes and oligodendrocytes. This transition from neurogenesis to gliogenesis represents a fundamental developmental switch in the vertebrate CNS, but the molecular mechanisms that drive progenitors toward glial fates are not fully understood. In this study, we identify Ascl1 as a conserved regulator of oligodendrocyte lineage specification and demonstrate that this function is regulated by phosphorylation downstream of FGF signaling. We used single-cell sequencing approaches in zebrafish spinal cord and mouse neocortex to show that Ascl1 is expressed in multipotent neural progenitor cells as they transition toward the oligodendrocyte lineage. Moreover, we performed loss of function experiments in zebrafish and mouse and found that Ascl1 promotes oligodendrocyte fate specification across species and CNS regions. We further demonstrated that phosphorylation of ASCL1 is required to direct progenitors toward OPC fate in the mouse neocortex, likely downstream of FGF signaling. Together, our data reveal an FGF-ASCL1 signaling axis that couples extrinsic signaling inputs to intrinsic transcriptional programs governing oligodendrogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.